Piramal Enterprises trades ex-demerger; NBFC business lists at Rs 1,050

August 30, 2022

Piramal Enterprises secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business and the simplification of its corporate structure, the company said in a regulatory filing. The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger on Tuesday as the markets will remain shut on Wednesday on the account Ganesh Chaturthi.

More To Explore

ITC Hotels to be removed from Sensex and BSE indices today

ITC Hotels share price: The newly demerged entity made its debut on the NSE and BSE at Rs 180 and Rs 188 per share, respectively,

February 5, 2025

Asian Paints shares in focus after Q3 results. Should you buy, sell, or hold?

The revenue from operations for Q3FY25 stood at Rs 8,549 crore, marking a 6% decline from Rs 9,103 crore reported in the corresponding quarter of

February 5, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003